| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgery (BMC, RPD, JJL, MFB) and Biostatistics (DL), Memorial Sloan-Kettering Cancer Center, New York, New York.
Correspondence: Address correspondence and reprint requests to: Dr. Murray F. Brennan, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021; Fax: 212-794-3184; E-mail: brennanm{at}mskcc.org
Introduction: The present study was undertaken to define the clinical differences between leiomyosarcomas (LMS) occurring within the abdomen and retroperitoneum and gastrointestinal stromal tumors (GIST).
Methods: It was a retrospective, single-institution review of patients treated for intra-abdominal and retroperitoneal GIST and LMS from July 1, 1982 through August 1, 1999.
Results: A total of 561 patients, 239 with GIST and 322 with LMS, were identified. Patients with GIST were older, with a median age of 58 years versus 54 years in the LMS group (P < .01). The majority of patients with GIST were male (58%), whereas 68% of LMS patients (excluding gender-specific sites) were female (P < .01). The 5-year disease-specific survival for GIST and LMS were 28% and 29%, respectively. The presentation status and ability to achieve a complete surgical resection were the main independent predictors of outcome for both GIST and LMS. Local and distant recurrence was common in both. The pattern of distant recurrence differed: 50% of all first-site GIST recurrences involved the liver, whereas 30% of all LMS first-site recurrences involved the lungs.
Conclusions: Although the two patient populations appear to be distinct, their clinical courses are similar. The pattern of distant spread follows the known patterns of hematogenous dissemination. Complete surgical resection is the cornerstone of treatment for primary GIST and LMS and in selected patients with local and distant recurrence.
Key Words: Gastrointestincal stromal tumor LeiomyosarcomaRetroperitoneal Sarcoma
This article has been cited by other articles:
![]() |
P. Rutkowski, Z. I. Nowecki, W. Michej, M. Debiec-Rychter, A. Wozniak, J. Limon, J. Siedlecki, U. Grzesiakowska, M. Kakol, C. Osuch, et al. Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor Ann. Surg. Oncol., July 1, 2007; 14(7): 2018 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Perez, J. C. Gutierrez, F. L. Moffat Jr, D. Franceschi, A. S. Livingstone, S. A. Spector, J. U. Levi, D. Sleeman, and L. G. Koniaris Retroperitoneal and Truncal Sarcomas: Prognosis Depends Upon Type Not Location Ann. Surg. Oncol., March 1, 2007; 14(3): 1114 - 1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Price, J. Trent, A. K. El-Naggar, D. Cogdell, E. Taylor, K. K. Hunt, R. E. Pollock, L. Hood, I. Shmulevich, and W. Zhang Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas PNAS, February 27, 2007; 104(9): 3414 - 3419. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. I. Andtbacka, C. S. Ng, C. L. Scaife, J. N. Cormier, K. K. Hunt, P. W. T. Pisters, R. E. Pollock, R. S. Benjamin, M. A. Burgess, L. L. Chen, et al. Surgical Resection of Gastrointestinal Stromal Tumors After Treatment with Imatinib Ann. Surg. Oncol., January 1, 2007; 14(1): 14 - 24. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Blair, W. B. Al-Refaie, J. Wang-Rodriguez, C. Behling, M.-W. Ali, and A. R. Moossa Gastrointestinal Stromal Tumors Express ras Oncogene: A Potential Role for Diagnosis and Treatment Arch Surg, June 1, 2005; 140(6): 543 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sandrasegaran, A. Rajesh, J. Rydberg, D. A. Rushing, F. M. Akisik, and J. D. Henley Gastrointestinal Stromal Tumors: Clinical, Radiologic, and Pathologic Features Am. J. Roentgenol., March 1, 2005; 184(3): 803 - 811. [Full Text] [PDF] |
||||
![]() |
M. T. Betts, E. J. Huo, and F. H. Miller Gastrointestinal and Genitourinary Smooth-Muscle Tumors Am. J. Roentgenol., November 1, 2003; 181(5): 1349 - 1354. [Full Text] [PDF] |
||||
![]() |
R. Pollock Soft Tissue Sarcoma: Setting the Stage Ann. Surg. Oncol., May 1, 2001; 8(4): 273 - 274. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |